ArticleBMC public health2026
Exploring frailty in the context of HIV and aging in Kazakhstan: findings from a pilot cross-sectional study.
Article in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundFrailty is increasingly recognized as an important morbidity among people living with HIV (PLHIV). However, no published data exist on its prevalence or determinants in Kazakhstan or Central Asia. This pilot study aimed to provide preliminary estimates of frailty prevalence and its associated factors among PLHIV in Almaty, Kazakhstan.
methodsWe conducted a cross-sectional pilot study at the Almaty Centre for AIDS Prevention and Control. A total of 100 PLHIV aged 40 years and older were recruited during routine clinical visits from a previous pilot study on cardiovascular health. Frailty was assessed via the Fried frailty Phenotype that included slow gait speed, weak grip strength, exhaustion, low physical activity, and unintentional weight loss. Participants meeting three or more criteria were classified as frail, and those meeting two or more criteria were classified as prefrail/frail. Logistic regression models were used to examine associations of prefrailty/frailty with HIV-related factors, multimorbidity (≥ 3 chronic conditions other than HIV), depressive symptoms, HIV-related stigmas, and expectations regarding aging.
resultsThe participants had a mean age of 50 years (SD 7.9), and 58% were male. The prevalence of frailty was 13%, whereas 40% met the criteria for prefrailty/frailty. Multimorbidity (adjusted odds ratio [AOR] 3.44, 95% confidence interval [CI] 1.40–8.79), depressive symptoms (AOR 1.09, 95% CI 1.02–1.19), internalized HIV-related stigma (AOR 1.25, 95% CI 1.05–1.56), and clinic-based HIV stigma (AOR 1.57, 95% CI 1.18–2.10) were associated with greater odds of prefrailty/frailty. Neurological, endocrine/metabolic, and noninfectious respiratory conditions were also significantly associated with the outcome. HIV-specific indicators such as the CD4 count and viral load were not significantly associated.
conclusionsFrailty is present among middle-aged and older PLHIV in Kazakhstan. Psychosocial factors and multimorbidity were more strongly associated with frailty than were HIV-specific indicators. As a pilot study with a modest sample size, these findings should be interpreted as preliminary but emphasize the need for larger-scale studies and interventions addressing frailty among PLHIV in the region.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.